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Interferon (IFN) signaling within the CNS
is critical for synaptic plasticity and
processes of learning and memory
formation under physiological conditions.
Hosseini et al. provide evidence that the
type I IFN receptor (IFNAR) is mediating
this effect via the glutamate-aspartate
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https://doi.org/10.1016/j.celrep.2020.107666SUMMARYType I interferon receptor (IFNAR) signaling is a hallmark of viral control and host protection. Here, we show
that, in the hippocampus of healthy IFNAR-deficient mice, synapse number and synaptic plasticity, as well as
spatial learning, are impaired. This is also the case for IFN-b-deficient animals. Moreover, antibody-mediated
IFNAR blocking acutely interferes with neuronal plasticity, whereas a low-dose application of IFN-b has a
positive effect on dendritic spine structure. Interfering with IFNAR signaling in different cell types shows a
role for cognitive function and synaptic plasticity specifically mediated by astrocytes. Intriguingly, levels of
the astrocytic glutamate-aspartate transporter (GLAST) are reduced significantly upon IFN-b treatment
and increase following inhibition of IFNAR signaling. These results indicate that, besides the prominent
role for host defense, IFNAR is important for synaptic plasticity as well as cognitive function. Astrocytes
are at the center stage of this so-far-unknown signaling cascade.INTRODUCTION
Type I interferons (IFNs) are crucial for viral control early after
infection (Fensterl et al., 2015; M€uller et al., 1994). However,
they can induce dose-dependent neuronal damage and behav-
ioral disturbances in both humans and animals (Crow andManel,
2015; Wilson et al., 2002). In mammals, IFN-a and IFN-b are the
most important type I IFN members, which bind to the common
type I IFN receptor (IFNAR) (Fensterl et al., 2015). Genetically
modified mice lacking the IFNAR1 subunit are devoid of a func-
tional IFN system and show enhanced susceptibility upon infec-
tion with viruses (M€uller et al., 1994). Interestingly, the roles of
IFN-a and IFN-b are not only limited to antiviral and immunomod-
ulatory actions, but both IFNs can also regulate homeostatic pro-
cesses in the periphery and the CNS (Blank and Prinz, 2017). Un-
der physiological conditions, low levels are thought to maintain
expression of STAT1 (Goldmann et al., 2016). Since STAT1 acti-
vates the transcription of a number of IFN-stimulated genes, it is
believed that this allows cells to enhance IFN-a/b production
rapidly as necessary via auto-amplification (Gough et al., 2010;
Tovey et al., 1987). Relatively low baseline levels were also de-
tected in the CNS by ELISA (Goldmann et al., 2016; Hwang
et al., 1995), and it is clear that all cell types of the CNS can pro-This is an open access article under the CC BY-Nduce and respond to IFN. Therefore, the question arises of
whether these low levels of IFNmight fulfill an additional purpose
beyond rendering the CNS ready to fight potential viral infection.
Evidence indeed suggests that IFN can promote the develop-
ment of cortical, hippocampal, and cholinergic neurons (Vikman
et al., 2001). IFN-b-deficient mice (Ifnb/) show increased
neuronal apoptosis and reduced neurite network formation (Ej-
lerskov et al., 2015), suggesting that in healthy conditions, base-
line levels of constant IFN secretion in the CNS contribute to
neuronal survival, branching, and neurite outgrowth. Further-
more, low-level IFN-b treatment (500–5000 U/ml) was sufficient
to protect neurons in vitro against HIV-1 envelope glycoprotein
120-induced neurotoxicity without any changes in neuronal sur-
vival (Thaney et al., 2017). In addition to the role of IFN for
neuronal development and survival, experiments have indicated
important roles of IFN for synaptic transmission and function
(Ignatowski and Spengler, 2008). Neurons express IFNAR on
both pre- and postsynaptic membranes (Vikman et al., 1998),
and IFNs have indeed been shown to modulate neuronal excit-
ability (Prieto-Gomez et al., 1983). On the other hand, it was
shown that high concentrations of IFN-a in rat hippocampal
acute slices led to a reduction in short-term potentiation and
impaired long-term potentiation (LTP) (D’Arcangelo et al., 1991;Cell Reports 31, 107666, May 19, 2020 ª 2020 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Impaired Cognitive Function and Synaptic Plasticity in Ifnar/ Animals
(A and B) Ifnar/ mice exhibited (A) a longer distance traveled with (B) higher average speed compared to WT mice.
(C) Time of both tested groups spent in the periphery versus the center part of the open-field arena did not differ between genotypes (n of mice inWT = 11, Ifnar/
n = 12).
(D) Ifnar/ mice showed a higher escape latency and, therefore, impaired spatial learning compared to WT animals.
(E) Percentage of time spent in the target quadrant (TQ) did not differ significantly between both tested groups during reference memory tests.
(F) Example tracks of searching strategies used during the Morris water maze training.
(G) A reduction in the use of the hippocampus-dependent strategy by Ifnar/ mice became apparent.
(H) Searching strategy quantification revealed that the hippocampus-dependent strategy was significantly decreased and hippocampus-independent strategies
were increased in Ifnar/ mice compared to WT (n of mice in WT = 10, Ifnar/ n = 12).
(I) Input-output curves showed no difference in basal synaptic transmission between WT and Ifnar/ mice.
(legend continued on next page)






OPEN ACCESSMendoza-Fernández et al., 2000). IFN signaling may therefore
act as a double-edged sword, which could be either detrimental
or neuroprotective, depending on the dose. However, the
detailed neurophysiological mechanisms involved in IFN
signaling, especially in the absence of infection, and its impor-
tance for cognitive function, such as memory formation, remain
elusive. Using either conventional or cell-type-specific IFNAR
knockout mice as well as a low-dose IFN-b application, we pro-
vide evidence that IFNAR signaling in astrocytes is involved in
synaptic plasticity and memory formation, possibly by modu-
lating glutamate-aspartate transporter (GLAST) expression.
RESULTS
IFNAR Signaling Regulates Hippocampal Function
In order to study the physiological role of IFNAR signaling in the
CNS for hippocampal function and synaptic plasticity, first, con-
ventional IFNAR-deficient mice (Ifnar/) were used (Figure 1).
To investigate general locomotor activity and to initially screen
for anxiety-related behavior, wild-type (WT) and Ifnar/ mice
were tested for 5 min in the open-field arena (Figures 1A–1C).
Ifnar/ mice traveled a significantly longer distance, with
higher average speed, compared to WT mice (distance, WT:
26.47 ± 1.59 m, Ifnar/: 37.61 ± 2.03 m, unpaired t test:
t = 4.25, df = 21, p = 0.0004; Figure 1A; speed, WT: 8.82 ±
0.53 cm/s, Ifnar/: 12.57 ± 0.66 cm/s, unpaired t test: t =
4.34, df = 21, p = 0.0003; Figure 1B). However, WT and
Ifnar/ mice spent comparable times in the periphery and cen-
ter zones of the open field (periphery, WT: 79.45% ± 3.80%,
Ifnar/: 83.59% ± 3.55%; center, WT: 20.54% ± 3.80%,
Ifnar/: 16.40% ± 3.55%; unpaired t test: t = 0.79, df = 21,
p = 0.43; Figure 1C). The results of this test, therefore, revealed
hyperactivity in Ifnar/ mice, but no significant alterations in
anxiety-related behavior. As a next step to identify the putative
role of IFNAR signaling for cognitive function, Ifnar/ and WT
mice were trained for 8 days in the Morris water maze. As shown
in Figure 1D, the escape latency progressively decreased over
8 days of acquisition training in WT animals, but not in Ifnar/
mice (one-way ANOVA: FWT(7, 72) = 16.29, p < 0.0001 and
FIfnar/(7, 88) = 1.31, p = 0.25). A day-by-day comparison of
the data between both tested groups also showed that the
escape latency on acquisition days 4 and 7 was significantly
higher in Ifnar/ animals compared to WT mice (two-way
ANOVA: FTreatment(1, 160) = 9.17, p = 0.002, Fisher’s LSD test:
day 4: p = 0.013, day 7: p = 0.03; Figure 1D). Both groups
were submitted to reference memory tests (probe trials without
the platform) on days 3 and 6 prior to the training session and
24 h after the last training session on day 9 (Figure 1E). On(J) No alteration was found in paired-pulse facilitation (PPF) between WT and Ifn
(K) Ifnar/ mice showed a significant impaired LTP induced by TBS.
(L) The mean LTP magnitude (T 75–80min) was significantly lower in Ifnar/ anim
(M and N) Spine density of (M) apical and (N) basal dendrites of CA1 pyramidal neu
show dendritic spines of hippocampal CA1 neurons in both tested groups (scale
(O) Microglia density and (P) number of primary processes as an indicator for the a
obvious signs of inflammation. Representative examples show anti-IBA-1 immuno
in each group = 4, n of ROIs in WT = 20, Ifnar/ = 18, n of randomly selected m
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, comparedays 6 and 9, Ifnar/ mice (day 6: 39.38% ± 4.11%; day 9:
43.57% ± 4.39%) spent slightly less time in the target quadrant
(TQ) compared to WT animals (day 6: 44.20% ± 3.24%; day 9:
49.12% ± 1.82%), although this difference was not statistically
significant (day 6, unpaired t test: t = 0.89, df = 20, p = 0.38;
day 9, unpaired t test: t = 1.08, df = 20, p = 0.29; Figure 1E).
To further analyze differences in the quality of spatial memory
formation, searching strategies were assessed (Figures 1F–1H).
The results revealed that in bothWT and Ifnar/mice, the use of
hippocampus-dependent direct swimming increased over the
training time. However, this progression was significantly
decreased in Ifnar/ mice compared to WT animals (day 7,
WT: 70% ± 5% and Ifnar/: 35.41% ± 8.95%; day 8, WT:
67.50% ± 6.50% and Ifnar/: 35.42% ± 7.82%), whereas hip-
pocampus-independent search strategies were significantly
increased, especially on days 7 and 8 of the acquisition training
in Ifnar/ animals, compared toWTmice (day 7,WT: 30% ± 5%
and Ifnar/: 64.59% ± 8.95%; day 8:WT: 32.50% ± 6.50% and
Ifnar/: 64.58% ± 7.82%; Fisher’s LSD, day 7: p = 0.003, day 8:
p = 0.005; Figures 1G and 1H).
The findings of the Morris water maze test indicated a hippo-
campus-dependent learning deficit in Ifnar/ mice. Therefore,
as a next step, hippocampal synaptic plasticity was investigated
to reveal potential cellular mechanisms responsible for this
deficit. For this purpose, field excitatory postsynaptic potentials
(fEPSPs) in the stratum radiatum of the hippocampal CA1 area
in response to stimulation of the Schafer collaterals were re-
corded from hippocampal slices of 6–8-week-old animals (Fig-
ures 1I–1L). The input-output curve of the fEPSP slope depen-
dence to the stimulation intensity did not reveal any significant
difference between Ifnar/ and WT mice (two-way ANOVA:
F(1, 282) = 2.64, p = 0.10; Figure 1I). Thus, basal synaptic trans-
missionwas not affected by IFNAR signaling deficiency. Analysis
of paired-pulse facilitation (PPF) of fEPSPs to afferent stimula-
tion, a form of short-term synaptic plasticity, was not affected
in the absence of IFNAR in hippocampal slices (two-way
ANOVA: F(1, 282) = 0.45, p = 0.49; Figure 1J). Next, to study
the role of IFNAR signaling in synaptic plasticity, LTP was
analyzed. LTP was induced by theta-burst stimulation (TBS). Sli-
ces of Ifnar/ mice showed a significantly impaired LTP
compared to WT animals (two-way ANOVA: F(1, 940) = 252.8,
p < 0.0001; Figure 1K). Also, the mean value of the maintenance
phase of LTP (displayed as the last 5 min of the recording)
was significantly diminished in Ifnar/ mice (WT: 1.40 ± 0.07,
Ifnar/: 1.13 ± 0.04, unpaired t test: t = 3.37, df = 47, p =
0.001; Figure 1L). To investigate the potential cellularmechanism
underlying the observed impairment in spatial learning and LTP in
Ifnar/ mice, hippocampal neuron morphology was studiedar/ mice.
als than in WT mice (n of slices in WT = 21, Ifnar/ n = 28).
rons was diminished in Ifnar/mice compared toWT. Representative images
bar, 2 mm; n of mice in each group = 4, n of dendrites in each group = 40).
ctivation status in the CA1 hippocampal subregion of Ifnar/mice showed no
staining of the CA1 region in both tested groups (scale bar, 10 mm; n of animals
icroglia in WT = 120, Ifnar/ = 108).
d to WT.
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morphology have been shown to correlate with defects in synap-
tic plasticity and cognitive function in general (Moser et al., 1994).
Dendritic spine counting on apical and basal dendrites (Figures
1M and 1N) of CA1 pyramidal neurons in the hippocampus of
Ifnar/ mice revealed a significant reduction (apical dendrite,
D-19.44%, unpaired t test: t = 7.15, df = 78, p < 0.0001; basal
dendrite,D-22.01%, unpaired t test: t = 8.19, df = 78, p < 0.0001).
Previously, it was shown that Ifnar/ mice are more sensitive
to infections, as they lack the first line of defense against viral
pathogens (M€uller et al., 1994; Wei et al., 2017). Therefore, to
confirm that the observed impairments in cognitive function
and synaptic plasticity were not due to neuroinflammation and
microgliosis, which might affect synaptic plasticity (Chhatbar
et al., 2018; Riazi et al., 2015), microglia density (Figure 1O)
and possible activation status (Figure 1P) in the CA1 hippo-
campal subregion of WT and Ifnar/ mice were assessed.
Microglia density did not differ in Ifnar/ mice compared to
WT mice (unpaired t test: t = 1.19, df = 36, p = 0.24; Figure 1O).
Earlier studies indicated that a reduced number of primary
processes can reflect an elevated activation status of microglia
(Papageorgiou et al., 2015; Wolf et al., 2017); however, no alter-
ations in the number of main processes were found in Ifnar/
compared to WT animals (unpaired t test: t = 0.47, df = 36, p =
0.63; Figure 1P). It therefore needs to be emphasized that IFNAR
deficiency was not associated with a detectable elevation of
neuroinflammation in the brain of healthy animals that would
lead to reduced synaptic plasticity and memory.
IFNAR Signaling in Astrocytes Regulates Hippocampal
Function
We showed that IFNAR signaling is crucial for hippocampal syn-
apse function. However, themechanisms, and especially the cell
types involved, remain elusive. Therefore, cell-type-specific
IFNAR deletion was used to determine the precise role of IFNAR
signaling in cognitive processes under healthy conditions.
For this purpose, NesCre+/IFNARfl/fl mice with a selective
IFNAR deletion in neuroectodermal cells of the CNS including
neurons, astrocytes, and oligodendrocytes, but not microglia
(Chhatbar et al., 2018; Detje et al., 2015, 2009), as well as
Syn1Cre+/IFNARfl/fl mice with neuron-specific IFNAR deletion
(Zhu et al., 2001) and GFAPCre+/IFNARfl/fl mice with astro-
cyte-specific IFNAR deletion (Bajenaru et al., 2002), were inves-
tigated. In this study, mice with negative Cre expression ob-
tained from mating between cell-specific promoter-driven Cre
transgenic mice and IFNARfl/fl animals were considered as
littermate control (Ctrl) animals. Cre-negative mice in all
three groups (NesCre/IFNARfl/fl, Syn1Cre/IFNARfl/fl, and
GFAPCre/IFNARfl/fl) exhibited similar characteristics without
any significant differences. As a consequence, we chose
NesCre/IFNARfl/fl mice (Nes-Cre-negative expression) as the
Ctrl group (Figure S1).
First, all conditional knockout mice were examined in the
open-field arena for 5 min (Figures 2A–2C). Analysis of the total
distance traveled (Figure 2A), average speed (Figure 2B), and
general activity in the periphery and center zones of the arena
(Figure 2C) revealed no significant differences from the Ctrl
group (distance, Ctrl: 21.88 ± 2.40 m, NesCre+/IFNARfl/fl:4 Cell Reports 31, 107666, May 19, 202027.10 ± 1.70 m, Syn1Cre+/IFNARfl/fl: 19.51 ± 2.12 m, GFAP-
Cre+/IFNARfl/fl: 22.89 ± 1.64 m; one-way ANOVA: F(3, 42) =
2.82, p = 0.0504; Figure 2A; speed, Ctrl: 7.28 ± 0.80 cm/s,
NesCre+/IFNARfl/fl: 9.03 ± 0.56 cm/s, Syn1Cre+/IFNARfl/fl:
6.50 ± 0.71 cm/s, GFAPCre+/IFNARfl/fl: 7.63 ± 0.54 cm/s;
one-way ANOVA: F(3, 42) = 2.83, p = 0.0502; Figure 2B; activity:
periphery, Ctrl: 86.66% ± 3.72%, NesCre+/IFNARfl/fl: 86.73% ±
1.90%, Syn1Cre+/IFNARfl/fl: 81.89% ± 6.08%, GFAPCre+/
IFNARfl/fl: 87.50% ± 3.14%; center, Ctrl: 13.34% ± 3.72%,
NesCre+/IFNARfl/fl: 13.26% ± 1.91%, Syn1Cre+/IFNARfl/fl:
18.10% ± 6.08%, GFAPCre+/IFNARfl/fl: 12.49% ± 3.14%;
one-way ANOVA: F(3, 42) = 0.41, p = 0.74; Figure 2C).
Next, the learning ability of cell-type-selective IFNAR knockout
mice was tested in the Morris water maze (Figures 2D and 2E).
While NesCre+/IFNARfl/fl and GFAPCre+/IFNARfl/fl animals
showed a learning impairment comparable to the full knockout,
the learning performance of Syn1Cre+/IFNARfl/flmicewas indis-
tinguishable from that of the Ctrl animals (one-way ANOVA:
FCtrl(7, 96) = 11.39, p < 0.0001; FNesCre(7, 104) = 0.97, p = 0.45;
FSyn1Cre(7, 88) = 4.06, p = 0.0007; FGFAPCre(7, 64) = 0.92, p =
0.49; FTreatment(3, 352) = 16.31, p < 0.001; Figure 2D). Results
of the reference memory tests showed that on probe trial day
6, the time spent by NesCre+/IFNARfl/fl animals (32.39% ±
3.84%) in the TQ was significantly less than the Ctrl group
(45.25 ± 4.25%, Fisher’s LSD, p = 0.04, Figure 2E). No significant
differences were observed for the time spent in the TQ between
Syn1Cre+/IFNARfl/fl and Ctrl mice (Fisher’s LSD, day 6: p = 0.61,
day 9: p = 0.24; Figure 2E). However, on probe trial day 9, Syn1-
Cre+/IFNARfl/fl mice (52.59% ± 4.01%) spent significantly more
time in the TQ compared to NesCre+/IFNARfl/fl (37.59% ±
4.54%; Fisher’s LSD, p = 0.01) and GFAPCre+/IFNARfl/fl mice
(33.01% ± 5.24%; Fisher’s LSD, p = 0.007; Figure 2E). Subse-
quently, the evaluation of the respective search strategies
(Figures S2A–S2D) displayed that the hippocampus-dependent
search strategy increased over time, while hippocampus-
independent search strategies decreased in the Ctrl and
Syn1Cre+/IFNARfl/fl groups (Figure S2B). This was not the
case in NesCre+/IFNARfl/fl and GFAPCre+/IFNARfl/fl mice
(two-way ANOVA: F(3, 352) = 10.53, p < 0.001; Figures S2C
and S2D). These data show that expression of IFNAR on neuro-
ectoderm-derived cells, specifically on astrocytes in the CNS, is
required for normal spatial learning and memory formation. In
line with this, the ablation of IFNAR signaling only in neurons
did not affect spatial learning and memory formation.
In the next step, synaptic plasticity was analyzed. fEPSPs
were recorded in conditional knockout and Ctrl mice. Here,
basal synaptic transmission (two-way ANOVA: F(3, 444) =
2.24, p = 0.08; Figure S2E) and PPF were also not affected
(two-way ANOVA: F(3, 444) = 2.41, p = 0.06; Figure S2F). In
line with the learning impairment, slices derived from NesCre+/
IFNARfl/fl and GFAPCre+/IFNARfl/fl mice exhibited a defect in
LTP compared to Ctrl mice, whereas Syn1Cre+/IFNARfl/fl
mice displayed normal LTP (two-way ANOVA: F(3, 1480) =
359.1, p < 0.0001; Figure 2F). In addition, the mean value of
the maintenance phase of LTP (T 75–80 min) was also signifi-
cantly reduced in NesCre+/IFNARfl/fl (1.15 ± 0.05, p <
0.0001) and GFAPCre+/IFNARfl/fl (1.24 ± 0.07, p = 0.007)
mice compared to the Ctrl (1.47 ± 0.04). Again, the mean value
Figure 2. IFNAR Expression Specifically in
Astrocytes Is Required for Normal Cognitive
Function and Synaptic Plasticity
(A–C) Results of the open-field test showed un-
changed (A) total distance traveled, (B) average
speed, and (C) activity percentage in the
periphery and center zones of the arena
between cell-type-specific IFNAR knockout and
respective Ctrl mice (n of mice in Ctrl = 11,
NesCre+/IFNARfl/fl = 14, Syn1Cre+/IFNARfl/fl =
12, GFAPCre+/IFNARfl/fl = 9).
(D) In the Morris water maze test,
NesCre+/IFNARfl/fl and GFAPCre+/IFNARfl/fl
mice showed higher escape latency than Ctrl ani-
mals (two-way ANOVA: F(2, 264) = 19.88, p <
0.0001); however, swimming time did not differ
between Syn1Cre+/IFNARfl/fl and Ctrl mice (two-
way ANOVA: F(1, 184) = 3.27, p = 0.07).
(E) On day 6 of the probe trial tests, only
NesCre+/IFNARfl/flmice spent significantly less time
in the TQ compared to Ctrl animals. On probe trial
day 9, both NesCre+/IFNARfl/fl and GFAPCre+/
IFNARfl/fl mice showed lower preference for the TQ
compared to Syn1Cre+/IFNARfl/fl animals (n of mice
in Ctrl = 13, NesCre+/IFNARfl/fl = 14, Syn1Cre+/
IFNARfl/fl = 12, GFAPCre+/IFNARfl/fl = 9).
(F) LTP was impaired in NesCre+/IFNARfl/fl and
GFAPCre+/IFNARfl/fl mice but not in Syn1Cre+/-
IFNARfl/fl animals.
(G) The mean LTP magnitude (T 75–80min) was
significantly lower in NesCre+/IFNARfl/fl and
GFAPCre+/IFNARfl/fl but not in Syn1Cre+/-
IFNARfl/fl mice in comparison to Ctrl animals (n of
slices in Ctrl = 22, NesCre+/IFNARfl/fl = 24, Syn1-
Cre+/IFNARfl/fl = 15, GFAPCre+/IFNARfl/fl = 17).
(H and I) Spine density of (H) apical and
(I) basal dendrites of CA1 hippocampal neurons
was decreased in NesCre+/IFNARfl/fl and
GFAPCre+/IFNARfl/fl mice compared to Ctrl
animals. Spine density was not altered in
Syn1Cre+/IFNARfl/fl mice. Representative images
show dendritic spines of hippocampal CA1 neu-
rons in all tested groups (scale bar, 2 mm; n of
mice in each group = 4, n of dendrites in each
group = 40).
Data are presented as mean ± SEM. *p < 0.05, *p <
0.01, ***p < 0.001, compared to Ctrl. #p < 0.05 and
##p < 0.01, compared to Syn1Cre+/IFNARfl/fl.
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(1.50 ± 0.06, p = 0.70) did not show any significant alterations
compared to the Ctrl group (one-way ANOVA: F(3, 74) = 8.76,
p < 0.0001; Figure 2G).
Moreover, significant reduction in the spine density of
apical and basal dendrites of CA1 pyramidal neurons
in NesCre+/IFNARfl/fl (apical: D-13.95%, Tukey’s test: p =
0.0002; basal: D-13.33%, Tukey’s test: p = 0.0003) and GFAP-
Cre+/IFNARfl/fl mice (apical: D-9.31%, Tukey’s test: p =
0.022; basal: D-9.18%, Tukey’s test: p = 0.023) was observed,
compared to the Ctrl group (Figures 2H and 2I). In line with
LTP observations, no significant changes in apical and basal
dendritic spine density were detected between Syn1Cre+/
IFNARfl/fl and Ctrl mice (apical: D+2.17%, Tukey’s test: p =
0.90; basal: D+4.04%, Tukey’s test: p = 0.58; Figures 2Hand 2I). As for the full knockout, the conditional knockout
mice displayed no signs of microgliosis (NesCre+/IFNARfl/fl,
density: unpaired t test: t = 0.30, df = 23, p = 0.76; activity: un-
paired t test: t = 1.21, df = 23, p = 0.23; GFAPCre+/IFNARfl/fl,
density: unpaired t test: t = 1.30, df = 38, p = 0.19; activity: un-
paired t test: t = 0.66, df = 38, p = 0.51; Figures S2G–S2I).
IFNAR Signaling Acutely Regulates Functional and
Structural Synaptic Plasticity
Cell-type-specific IFNAR ablation showed that IFNAR signaling
is involved in hippocampal synaptic plasticity and cognitive func-
tion in the healthy brain. To understand whether this might
indeed be due to an acute role, we applied an IFNAR blocking
antibody (10 mg/ml) or IgG1 k isotype Ctrl antibody (10 mg/ml)
on hippocampal slices (Figure 3). Following 1 h pre-treatment,Cell Reports 31, 107666, May 19, 2020 5
Figure 3. Acute Blocking of IFNAR Signaling Revealed a Direct Effect on Activity-Dependent Functional and Structural Synaptic Plasticity
(A) Input-output relationship (n of slices in Ctrl = 10, IgG1 Ab = 10, IFNAR Ab = 10), and (B) PPF were not altered in slices treated with the IFNAR blocking antibody,
compared to IgG1-antibody-treated and untreated Ctrl slices (n of slices in Ctrl = 10, IgG1 Ab = 9, IFNAR Ab = 9).
(C) LTP was impaired in IFNAR-blocking-antibody-treated slices (n of slices in Ctrl = 10, IgG1 Ab = 10, IFNAR Ab = 9).
(D) The mean LTP magnitude (T 75–80 min) was lower in IFNAR-antibody-treated slices compared to IgG1-antibody-treated and untreated Ctrl slices.
(E) Spine density in IFNAR-blocking-antibody-treated compared to IgG1-antibody-treated and untreated Ctrl cells did not show any significant differences with
and without cLTP induction (n of cells in Ctrl = 59, IgG1 Ab = 25, IFNAR Ab = 20, cLTP+Ctrl = 40, cLTP+IgG1 Ab = 20, cLTP+IFNAR Ab = 26).
(F) Spine-head diameter did not further increase following co-treatment of the IFNARblocking antibody (10 mg/ml) and glycine and strychnine (cLTP), compared to
IgG1-antibody-treated and untreated Ctrl slices (n of randomly selected spines per each dendrite = 20, n of cells in Ctrl = 52, IgG1 Ab = 25, IFNAR Ab = 20,
cLTP+Ctrl = 33, cLTP+IgG1 Ab = 26, cLTP+IFNAR Ab = 26).
(G) Representative images of dendritic spines of hippocampal neurons in all tested groups (scale bar, 2 mm).




OPEN ACCESSno significant difference in the fEPSP slope size was detected
(two-way ANOVA F(2, 162) = 0.78, p = 0.46; Figure 3A). PPF
was also not altered following the IFNAR blocking antibody treat-
ment (two-way ANOVA F(2,150) = 0.48, p = 0.62; Figure 3B). In
line with our data on Ifnar/ mice, slices pre-treated with the
IFNAR blocking antibody showed a significant impairment in
LTP compared to the slices pre-treated with the Ctrl antibody
and the untreated slices (two-way ANOVA F(2, 520) = 62.57,
p < 0.0001; Figure 3C). Also, the mean value of the maintenance
phase of LTP (last 5 min of recording) was significantly dimin-
ished in IFNAR-blocking-antibody-treated slices (1.26 ± 0.08),
thereby revealing an impairment in synaptic plasticity, compared
to the slices treated with the Ctrl antibody (1.70 ± 0.13, unpaired t
test: t = 2.66, df = 17, p = 0.016) and the untreated slices (1.57 ±
0.11, unpaired t test: t = 2.16, df = 17, p = 0.045; Figure 3D).
These results show that IFNAR signaling is acutely involved in
functional synaptic plasticity under physiological conditions.
Furthermore, we were interested in whether not only functional,
but also structural, synaptic plasticity would be directly affected
by IFNAR signaling. Therefore, LTP was induced chemically
(cLTP) by using glycine and strychnine (Fortin et al., 2010) in pri-
mary embryonic hippocampal cultures treated with either the
IFNAR blocking antibody (10 mg/ml) or the IgG1 k isotype Ctrl
antibody (10 mg/ml) (Figures 3E–3G). While dendritic spine den-6 Cell Reports 31, 107666, May 19, 2020sity was not altered following the IFNAR blocking antibody treat-
ment (one-way ANOVA F(5, 184) = 1.14, p = 0.33; Figure 3E), the
observed activity-dependent spine-head enlargement after
cLTP induction in Ctrl cells, compared to unstimulated Ctrl cells,
was completely prevented by application of the IFNAR blocking
antibody (unstimulated, Ctrl: 0.55 ± 0.009 mm; IgG1: 0.51 ±
0.01 mm; IFNAR Ab:0.56 ± 0.01 mm; cLTP, Ctrl: 0.68 ± 0.01 mm;
IgG1: 0.62 ± 0.01 mm; IFNAR Ab: 0.54 ± 0.01 mm, one-way
ANOVA: F(5, 176) = 20.69, p < 0.0001; Figures 3F and 3G). We
can, therefore, show that both functional and structural plasticity
are acutely dependent on IFNAR-mediated signaling pathways.
IFN-b Is Involved in Regulating Hippocampal Synaptic
Plasticity
Since IFN-a is not present in the healthy CNS (Detje et al.,
2009), IFN-b might be the major IFN involved in the homeo-
static role of IFNAR signaling in the CNS described above.
To confirm the role of IFN-b in cognitive function and synaptic
plasticity under physiological conditions, Ifnb/ animals were
utilized (Figure 4). Analysis of the total distance traveled (Fig-
ure 4A) and average speed in the open field (Figure 4B) did not
reveal any significant differences between Ifnb/ and WT
mice (distance, WT: 16.29 ± 1.66 m, Ifnb/: 18.86 ± 1.49;
unpaired t test: t = 1.09, df = 17, p = 0.28; speed,
Figure 4. Impaired Cognitive Function and Synaptic Plasticity in Ifnb/ Mice
(A and B) In Ifnb/ mice, (A) total distance traveled and (B) average speed were not altered significantly compared to WT mice.
(C) Ifnb/ mice exhibited more time spent in the periphery and less time spent in the center zone of the open-field arena. Ifnb/ mice exhibited significantly
increased anxiety-related behavior compared to WT mice (n of mice in WT = 11, Ifnb/ = 8).
(D) In the Morris water maze test, Ifnb/ mice showed higher escape latency and, therefore, impaired spatial learning compared to WT animals.
(E) On probe trials days 6 and 9, Ifnb/ mice spent significantly less time in the TQ compared to WT animals.
(F) Example tracks of learning strategies used during the Morris water maze training.
(G) A reduction in the use of the hippocampus-dependent strategy by Ifnb/ mice became apparent.
(H) Quantification of searching strategies showed that the hippocampus-dependent strategy was decreased, and hippocampus-independent strategies were
increased in Ifnb/ mice, compared to WT (n of mice in WT = 11, Ifnb/ = 8).
(I) Basal synaptic transmission was not altered in both tested groups (n of slices in WT = 17, Ifnb/ = 21).
(J) PPF was not different between Ifnb/ and WT mice (n of slices in WT = 14, Ifnb/ = 21).
(K) LTP was impaired in Ifnb/ mice.
(L) The mean LTP magnitude (T 75–80 min) was lower in Ifnb/ mice compared to WT mice (n of slices in WT = 14, Ifnb/ = 16).
(M and N) Spine density of (M) apical and (N) basal dendrites of CA1 pyramidal hippocampal neurons was reduced in Ifnb/ mice compared to WT mice.
Representative images of dendritic spines of hippocampal CA1 neurons in both tested groups (scale bar, 2 mm; n of mice inWT = 3, Ifnb/ = 4, n of dendrites in in
WT = 30, Ifnb/ = 40-42).
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, compared to WT.
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OPEN ACCESSWT: 5.43 ± 0.56 cm/s, Ifnb/: 6.31 ± 0.49 cm/s; unpaired t
test: t = 1.11, df = 17, p = 0.27). However, Ifnb/ mice spent
significantly more time in the periphery and less time in thecenter zones of the open-field arena than the WT mice (pe-
riphery, WT: 71.41% ± 3.94%, Ifnb/: 86.45% ± 2.21%; cen-
ter, WT: 28.58% ± 3.94%, Ifnb/: 13.55% ± 2.21%; unpairedCell Reports 31, 107666, May 19, 2020 7
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OPEN ACCESSt test: t = 2.99, df = 17, p = 0.008; Figure 4C), indicating an
increased anxiety-related behavior in Ifnb/ mice.
Escape latency in the Morris water maze progressively dimin-
ished over 8 days of acquisition training inWT animals, but not in
Ifnb/ mice (one-way ANOVA: FWT(7, 80) = 11.39, p < 0.0001
and FIfnb/(7, 56) = 0.62, p = 0.73). A day-by-day comparison
of the data also showed a significantly higher escape latency
during acquisition days 6–8 in Ifnb/ mice compared toWT an-
imals (two-way ANOVA: FTreatment(1, 136) = 28.01, p < 0.0001,
Fisher’s LSD test - day 6: p = 0.005, day 7: p = 0.017, day 8:
p = 0.001; Figure 4D). On probe trials days 6 (WT: 45.98% ±
4.22%, Ifnb/: 21.42% ± 4.78%) and 9 (WT: 60.24% ±
4.36%, Ifnb/: 31.58% ± 10.47%), Ifnb/ mice spent signifi-
cantly less time in the TQ compared to WT animals (day 6, un-
paired t test: t = 3.82, df = 17, p = 0.0014; day 9, unpaired
t test: t = 2.80, df = 17, p = 0.01; Figure 4E). Also, analysis of
the searching strategies revealed that in WT mice, the use of
the hippocampus-dependent and hippocampus-independent
search strategies increased and decreased, respectively, over
8 days of acquisition training, whereas this was not the case
for Ifnb/ mice (Figures 4F and 4G). A quantification showed
significantly fewer hippocampus-dependent (WT: 45.45% ±
8.13%, Ifnb/: 9.37% ± 6.57%, Fisher’s LSD: p = 0.0007) and
more hippocampus-independent (WT: 54.54% ± 8.13%,
IFN-b/: 90.62% ± 6.57%, Fisher’s LSD: p = 0.0007) searching
strategies in Ifnb/ mice compared to WT, especially on day 8
(Figure 4H). These findings revealed learning and memory defi-
cits in Ifnb/ mice.
As a next step, hippocampal synaptic plasticity was investi-
gated to discover the potential cellular mechanisms responsible
for this deficit (Figures 4I–4L). While Ifnb/ mice showed no im-
pairments in baseline synaptic transmission (two-way ANOVA:
F(1, 216) = 1.47, p = 0.23; Figure 4I) or PPF (two-way ANOVA:
F(1, 198) = 0.80, p = 0.37; Figure 4J), LTP was significantly
impaired in Ifnb/ animals (two-way ANOVA: F(1, 560) =
60.39, p < 0.0001; Figure 4K). A reduced mean value of LTP
(T 75–80 min) in Ifnb/ mice (1.27 ± 0.046) was observed
compared to in WT (1.57 ± 0.09, unpaired t test: t = 3.094, df =
28, p = 0.004; Figure 4L). In addition, a significant reduction in
the spine density of apical and basal dendrites of CA1 pyramidal
neurons (Figures 4M and 4N) in Ifnb/ mice, compared to WT
animals, was detected (apical: D-20.92%, unpaired t test: t =
7.97, df = 70, p < 0.0001; basal: D-16.14% unpaired t test: t =
6.34, df = 68, p < 0.0001).
Next, in a gain-of-function approach, we applied IFN-b at a low
dose (1000 U/ml) with and without cLTP induction in primary
embryonic hippocampal cultures, as described above (Figures
5A–5C). Again, a significant difference in spine density was not
detected among all tested groups (one-way ANOVA: F(3,
116) = 2.55, p = 0.06; Figure 5A). cLTP induction resulted in a
highly significant increase in spine-head diameter in the cLTP
Ctrl group (0.62 ± 0.01 mm) compared to the untreated Ctrl cells
(0.48 ± 0.008 mm, Tukey’s test: p < 0.0001). The application of
IFN-b together with cLTP induction did not lead to a significant
further increase in spine-head diameter (0.67 ± 0.01 mm)
compared to cLTP induction alone (Tukey’s test: p = 0.12).
Yet, the application of IFN-b already under baseline conditions
significantly increased spine-head size (0.60 ± 0.01 mm, Tukey’s8 Cell Reports 31, 107666, May 19, 2020test: p < 0.0001), comparable to that observed after cLTP induc-
tion (one-way ANOVA: F(3, 116) = 44.34, p < 0.0001; Figures 5B
and 5C). These results suggest that a low-dose application of
IFN-b in a physiological range is sufficient to induce spine struc-
tural plasticity. Next, to investigate whether the effect of the
IFN-b application is indeed IFNAR specific, primary embryonic
hippocampal cultures obtained from Ifnar/ mice were treated
with IFN-b (1000 U/ml) alone or together with glycine and strych-
nine (cLTP induction) (Figures 5D–5F). Results did not reveal
any significant differences in spine density (one-way ANOVA:
F(3, 116) = 1.25, p = 0.29; Figure 5D) or in spine-head diameter
(one-way ANOVA: F(3, 116) = 1.12, p = 0.34; Figure 5E) among
all experimental groups. Moreover, similar spine-head diameter
in both unstimulated (0.50 ± 0.01 mm) and stimulated (0.49 ±
0.01 mm, Tukey’s test: p = 0.90) Ifnar/ cultures with glycine
and strychnine indicated impaired cLTP induction in Ifnar/
neurons, whichwas in linewith our in vivo observations (Figure 1).
As the activity-dependent spine-head enlargement following
cLTP induction is mediated by glutamate receptors, we were
interested in understanding whether IFNAR-mediated effects
on structural synaptic plasticity were dependent on ionotropic
glutamate receptors. Therefore, primary embryonic hippocam-
pal cultures obtained from WT mice were treated with IFN-b
alone or together with APV (D-2-amino-5-phosphonovalerate)
and CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium)
(ionotropic glutamate receptor inhibitors [iGluR Is]; Figures 5G–
5I). Spine density was not altered in all groups tested (one-way
ANOVA: F(2, 62) = 0.16, p = 0.85; Figure 5G). However, IFN-b
treatment (0.62 ± 0.01 mm) led to a significant increase in
spine-head diameter compared to the Ctrl cells (0.52 ±
0.008 mm, Tukey’s test: p < 0.0001). Blocking theNMDA receptor
(NMDAR) and AMPA receptor (AMPAR) by APV and CNQX in-
hibited the IFN-b mediated increase in dendritic spine-head
diameter (0.55 ± 0.01 mm, Tukey’s test: p = 0.31; Figures 5H
and 5I). These findings suggest that synaptic plasticity induced
by low levels of IFN-b is dependent on iGluRs. In conclusion,
IFN-b regulates spine plasticity by inducing structural changes
in dendritic spines via iGluRs.
IFNAR Signaling Regulates GLAST Expression on
Astrocytes toModulate Hippocampal Synaptic Plasticity
Our in vivo experiments revealed that astrocytes are themain cell
type involved in IFNAR-mediated effects on synaptic plasticity;
therefore, we were interested in the pathways that might be
involved in modulating neuron-glia crosstalk in this scenario.
Previously, it was shown that IFN-b can alter astrocyte-specific
GLAST expression (Costello and Lynch, 2013). Therefore, we
investigated whether the expression of GLAST would be regu-
lated following IFN-b treatment in primary embryonic hippocam-
pal cultures (Figures 6A and 6B). Anti-GLAST immunostaining re-
vealed that a low-dose application of IFN-b (1000 U/ml) led to a
significant reduction in the expression level of GLAST in astro-
cytes (20.25% ± 2.45%) in primary embryonic hippocampal cul-
tures compared to untreated cultures (29.83% ± 2.85%, Fisher’s
LSD: p = 0.025). On the other hand, GLAST expression was
elevated significantly following application of the IFNAR blocking
antibody (39.7% ± 5.09%, Fisher’s LSD: p = 0.049; Figures 6A
and 6B). As a next step, GLAST expression was determined in
Figure 5. Low-Dose IFN-b Application Induces Positive Spine Structural Plasticity
(A and B) Upon IFN-b (1000 U/ml) treatment of primary embryonic hippocampal cultures derived from WT mice for 10 min (A) assessment of spine density in all
treatments compared to untreated cells (Ctrl) did not show any significant differences. (B) IFN-b (1000 U/ml) treatment led to a significant increase in dendritic
spine-head diameter. Co-treatment of IFN-b together with cLTP induction revealed no additional spine-head growth.
(C) Representative images of dendritic spines of hippocampal neurons in all treated cells derived fromWTmice (scale bar, 2 mm; n of cells in Ctrl = 40, IFN-b = 20,
cLTP+Ctrl = 40, cLTP+IFN-b = 20, n of randomly selected spines per each dendrite = 20).
(D and E) IFN-b (1000 U/ml) treatment of primary embryonic hippocampal cultures derived from Ifnar/mice alone or together with cLTP for 10min did not show
any significant differences in (D) dendritic spine density and (E) head diameter.
(F) Representative images of dendritic spines of hippocampal neurons in all treated cells derived from Ifnar/mice (scale bar, 2 mm; n of cells in each group = 30,
n of randomly selected spines per each dendrite = 20).
(G and H) The administration of 1000 U/ml IFN-b alone or accompanied by APV and CNQX did not alter dendritic spine density; however, (H) co-application of
IFN-b and ionotropic glutamate receptor inhibitors (iGluR Is) showed that the positive effect of IFN-b on spine-head diameter is dependent on ionotropic
glutamate receptor signaling.
(I) Representative images of dendritic spines of hippocampal neurons in all tested groups (scale bar, 2 mm; n of cells in Ctrl = 15, IFN-b = 30, IFN-b+iGluR Is = 20 n
of randomly selected spines per each dendrite = 20).
Data are presented as mean ± SEM. ***p < 0.001, compared to Ctrl.
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knockout mice using immunohistochemistry (Figures 6C and
6D) and western blotting (Figure 6E). While no alterations in
GLAST expression were observed in the Syn1Cre+/IFNARfl/fl
mice (immunostaining:D-0.76%, Fisher’s LSD: p = 0.93; western
blotting: D+6.6%, Fisher’s LSD: p = 0.87), GLAST levels were
significantly increased in the hippocampus of Ifnar/ (immuno-
staining: D+26%, Fisher’s LSD: p = 0.005; western blotting:
D+189.6%, Fisher’s LSD: p < 0.0001), NesCre+/IFNARfl/fl
(immunostaining: D+21%, Fisher’s LSD: p = 0.023; western
blotting: D+190.2%, Fisher’s LSD: p < 0.0001), and GFAPCre+/
IFNARfl/fl mice (immunostaining: D+41.7%, Fisher’s LSD: p <
0.0001; western blotting: D+204.5%, Fisher’s LSD: p < 0.0001)
compared to WT animals (Figures 6C–6E). These findings sug-
gest that dysregulation of glutamate homeostasis, following IF-NAR ablation specifically in astrocytes, may be at least partly
responsible for impaired hippocampal synaptic plasticity. Addi-
tional evidence comes from experiments where we partially
blockedGLAST activity by application of a glutamate transporter
inhibitor (TFB-TBOA), which indeed mimicked the positive ef-
fects of low concentrations of IFN-b on spine structural plasticity
(Figures 6F and 6G). TFB-TBOA is a selective inhibitor of gluta-
mate transporters EAAT1, EAAT2, and EAAT3 in glial cells
(Bozzo and Chatton, 2010). While no significant differences in
dendritic spine density were detected among the different
treated groups (one-way ANOVA: F(3, 88) = 1.24, p = 0.29;
Figure 6F), administration of TFB-TBOA alone (0.55 ± 0.01 mm,
Tukey’s test: p = 0.0002) or accompanied by cLTP induction
(0.53 ± 0.01 mm, Tukey’s test: p = 0.01) led to a significant eleva-
tion in dendritic spine-head diameter compared to untreated CtrlCell Reports 31, 107666, May 19, 2020 9
Figure 6. Signaling of IFN-b via the IFNAR in Astrocytes Involves Modulation of the Glutamate Transporter GLAST
(A) Representative examples of anti-GLAST and anti-GFAP immunostaining in primary embryonic hippocampal cultures (scale bar, 10 mm).
(B) Anti-GLAST immunocytochemistry in primary embryonic hippocampal cultures showed a significant reduction or elevation in GLAST expression levels
following application of IFN-b (1000 U/ml) or IFNAR blocking antibody (10 mg/ml), respectively (n of cells in Ctrl = 30, IFN-b = 24, IFNAR Ab = 14).
(C) Representative examples of anti-GLAST immunohistochemistry in the CA1 region of WT, conventional, and conditional IFNAR knockout mice (scale bar,
50 mm).
(D) GLAST expression was higher in the CA1 hippocampal subregion of Ifnar/, NesCre+/IFNARfl/fl, and GFAPCre+/IFNARfl/fl, but not of Syn1Cre+/IFNARfl/fl
mice, compared to WT animals (n of mice in each group = 3, n of ROIs per each mouse = 5).
(E) In addition, GLAST expression was determined by western immunoblot, and values were normalized to GAPDH. Here as well, GLAST expression was
significantly increased in the hippocampus of Ifnar/, NesCre+/IFNARfl/fl, and GFAPCre+/IFNARfl/fl, but not in Syn1Cre+/IFNARfl/fl mice, compared to
respective Ctrl animals (n of samples inWT = 20, NesCre+/IFNARfl/fl = 22, Syn1Cre+/IFNARfl/fl = 15, GFAPCre+/IFNARfl/fl = 21). Insets illustrate representative
blots of GLAST along with respective GAPDH blots.
(F and G) Upon TFB-TBOA (20 nM) treatment of primary embryonic hippocampal cultures for 10min (F) spine density in all treatments compared to untreated Ctrl
cells did not show any significant differences. (G) TFB-TBOA (20 nM) treatment led to a significant elevation in dendritic spine-head diameter. Treatment of TFB-
TBOA (20 nM) and cLTP induction did not lead to an additional spine-head increase. n of cells in Ctrl = 25, TBOA = 27, cLTP+Ctrl = 22, cLTP+TBOA = 18.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, compared to WT (A–E) and (F and G) Ctrl.
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0.0001; Figure 6G). In summary, we can show with our in vitro
data that IFNAR signaling leads to structural spine-head plas-
ticity by decreasing astrocytic glutamate uptake.
DISCUSSION
The most important cytokines involved in brain-immune interac-
tion both under physiological and pathological conditions are in-
terleukins (ILs), tumor necrosis factor alpha (TNF-a), and IFNs.
IFN-a and IFN-b are the predominant type I IFNs in the CNS,10 Cell Reports 31, 107666, May 19, 2020so far mostly implicated as important mediators of antiviral im-
mune responses. All CNS cell types, including neurons and glial
cells, are able to produce and respond to IFNs (Owens et al.,
2014). Earlier studies revealed that immune-deficient mice are
more susceptible to mental stress, suffer from cognitive deficits,
and show reduced levels of hippocampal neurogenesis when
compared to their WT counterparts (Deczkowska et al., 2016;
Ziv et al., 2006). The hippocampus is a highly plastic brain region,
involved in learning and memory formation, which are especially
sensitive to cytokines (Hosseini et al., 2018; Korte and Schmitz,
2016). In this study, we were therefore interested in a possible
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OPEN ACCESSphysiological role of IFNAR signaling for cognitive function in
general and for learning and memory formation in particular.
For this purpose, conventional as well as different conditional
knockout mouse lines for IFNAR signaling were investigated.
Interestingly, IFNAR ablation led to a strong impairment in mem-
ory formation in conventional Ifnar/ mice, which was associ-
ated with deficits in hippocampal LTP and reduced dendritic
spine density. Memory retrieval during probe trials in the Morris
water maze, however, was only mildly impaired, suggesting that
other areas in the CNS, like parts of the neocortex, might be less
affected than the highly vulnerable hippocampal CA1 region. It
needs to be emphasized that no signs of microgliosis in the
absence of IFNAR could be detected. Further detailed analysis
might be used in the future to determine whether there would
be more subtle signs of microgliosis and astrogliosis in this
context. The strong impairments in synaptic plasticity, synapse
number, and memory formation imply that IFNAR signaling is
also involved in brain function in the absence of viral infection un-
der physiological states. This phenomenon has been also
described for other cytokines, including IL-1b and TNF-a
(McAfoose and Baune, 2009; Santello et al., 2011). We next
addressed which cell types would be the most important IFN re-
sponders. While a pure neuronal knockout did not recapitulate
the phenotype observed in Ifnar/mice, IFNAR loss specifically
in astrocytes almost completely mimicked the phenotype.
Cognitive impairments might partly result from developmental
alterations in neuronal network formation in the absence of
IFNAR signaling. It was indeed shown previously that astrocytes
release glutamate, ATP, and cytokines such as TNF-a and type I
IFN that change the survival rate and function of newly formed
connections between neurons (Ota et al., 2013). Furthermore,
it has been shown that cytokines such as IFN are able to control
neurogenesis and brain development by modulating growth, dif-
ferentiation, and survival of neuronal cells (Mehler and Kessler,
1998). For instance, IFN-treated fetal murine neuroblast cultures
developed a differentiated neuronal population associated with
the expression of mature neurofilament proteins (Plioplys,
1988). In addition, JAK-STAT signaling downstream of many cy-
tokines, such as type I IFN and IL-2, IL-6, IL-10, and TNF-a (Mur-
ray, 2007), plays a critical role in various brain developmental
pathways, especially in promoting astrogliogenesis (Lee et al.,
2016). Astrocytes, in turn, are known to substantially contribute
to CNS development by controlling synaptogenesis and axon
guidance factors (Chung et al., 2015b). During development, as-
trocytes release and respond to other factors such as brain-
derived neurotrophic factor (BDNF), transforming growth factor
b (TGF-b), and thrombospondin (TSP), thereby controlling gluta-
matergic synapse formation (Chung et al., 2015b). Previously, it
was shown that in Down syndrome, elevated IFN-g levels are
associated with a reduction in TSP-1 secretion from astrocytes
(Garcia et al., 2010). Therefore, physiological levels of IFNAR
signaling and subsequent activation of JAK-STAT pathways
might be important for astrocyte maturation and function, which
in turn could regulate neuronal network development and func-
tion (de Araujo et al., 2009). In addition to the possible chronic ef-
fect of IFNAR loss on neuronal network formation, our data pre-
sented here provide evidence for a direct and acute effect of
IFNAR signaling on synaptic plasticity and hippocampal func-tion. Previously, it was shown that cytokines are able to exert
neuroprotective effects (Carlson et al., 1999). Thus, elucidation
of the detailed mechanisms by which immune molecules can
affect neuronal function has important implications to under-
stand the balance between beneficial effects during normal brain
function and adverse effects of cytokine signaling during pro-
cesses of inflammation. There is indeed evidence for the contri-
bution of cytokines to the acquisition, consolidation, and
retrieval of memories (Donzis and Tronson, 2014). For instance,
several studies revealed an important role for IL-1b for hippo-
campus-dependent memory formation. The levels of IL-1b are
reported to increase during LTP induction or following context-
dependent fear conditioning, suggesting a critical role of this
cytokine in learning and memory formation (Schneider et al.,
1998). In addition, it has been shown that low levels of IL-1b
have a physiological role in the maintenance phase of LTP,
whereas high pathological concentrations inhibit LTP (Schneider
et al., 1998). The levels of TNF-awere also shown to increase af-
ter learning; however, this cytokine seems not to be directly
important for learning and memory consolidation (Belarbi et al.,
2012). Recent studies showed that TNF-a released from astro-
cytes can act as a gliotransmitter by promoting the membrane
insertion of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptors in neurons (Theodosis et al., 2008).
Therefore, the constitutive release of physiological levels of
TNF-a contributes to the homeostatic activity-dependent regu-
lation of synaptic connectivity (Stellwagen and Malenka, 2006).
IFNs can also act as neuromodulators, which are able to exert
direct effects on synaptic transmission and function (Costello
and Lynch, 2013; Hadjilambreva et al., 2005). Differential
signaling outcomes of IFN-a and IFN-b can determine whether
type I IFN exert pathogenic or protective roles in the CNS, de-
pending on their concentration (Owens et al., 2014). Using hip-
pocampal slices, we showed here that blocking IFNAR acutely
resulted in impairments in functional and structural plasticity.
Moreover, a low-dose application of IFN-b alone, as a major
ligand for IFNAR, was already sufficient to induce spine-head
plasticity. In line with this, we showed impaired spatial memory
formation and LTP, as well as reduced dendritic spine density
in adult Ifnb/ mice. Indeed, it was previously reported that
these mice show behavioral and cognitive impairments as well
as neurodegeneration later in life (Ejlerskov et al., 2015). Our re-
sults, therefore, indicate a direct role of IFNAR signaling in astro-
cytes for synaptic plasticity and cognitive function. It could be
shown previously that conditional astrocyte-specific IL-1 recep-
tor knockout mice display memory deficits (Ben Menachem-Zi-
don et al., 2011). A possible mechanism might be the regulation
of available glutamate in the synaptic cleft by glutamate trans-
porters GLT-1 and GLAST, which indeed have been shown to
promote LTP (Swanson, 2005). Previously, it was reported that
by releasing and responding to different cytokines such as
TNF-a, CCL2, and IL-1, astrocytes are involved in different as-
pects of synaptic plasticity by regulating glutamate transport at
the synapse, as well as the insertion of AMPA receptors and in-
hibition of NMDA receptor activity (Ota et al., 2013). It was shown
that constitutive TNF-a in the hippocampus, specifically in the
dentate gyrus, activates astrocyte P2Y1 receptors and subse-
quently induces localized Ca2+ elevations, followed by glutamateCell Reports 31, 107666, May 19, 2020 11
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potentiation (Santello et al., 2011). Here, we showed that a
low-dose application of IFN-b or the IFNAR blocking antibody
led to a decrease or increase, respectively, in astrocytic GLAST
expression, suggesting that glutamate uptake modulation might
directly affect synaptic activity. In addition, the treatment of hip-
pocampal cultures with TFB-TBOA as a selective inhibitor of glial
glutamate transporters mimicked the positive effects of low con-
centrations of IFN-b on spine structural plasticity. Therefore, the
regulation of astrocytic glutamate transports, and thereby avail-
able glutamate at the synapse, may represent a possible mech-
anism by which type I IFNs are involved in directly modulating
synaptic plasticity and cognitive function.
Taken together, this study shows that in the absence of viral
infection, IFNAR signaling, most likely by modulating neuron-
astrocyte crosstalk, is crucial for synapse numbers as well as
synaptic plasticity and cognitive function. We provide evidence
that IFNAR signaling at physiological levels regulates GLAST
expression in astrocytes and thereby might represent a crucial
mechanism to modulate neuronal excitability during synaptic
plasticity (Chung et al., 2015a). However, because microglia
are one of the major type-I-IFN-producing cells and, at the
same time, are also highly responsive to it (Goldmann et al.,
2016), we cannot ignore the importance of microglia in IFNAR
signaling for controlling brain homeostasis and function. Inter-
estingly, phenotypes such as anxiety-related behavior in Ifnb/
mice and hyperactivity or the strongest reduction in dendritic
spine number were detectable only in conventional IFNAR
knockout mice, but not in mice showing a neuroectodermal
cell-selective IFNAR deletion, suggesting that IFNAR triggering
of some other CNS-resident cell type accounts for these effects.
The findings of this study are also of special interest, as type I IFN
inhibitors are used for therapeutic purposes in patients with
lupus or other severe inflammatory diseases. Inhibition of high
levels of type I IFNs in the brains of these patients might present
a new therapeutic strategy for preventing possible CNS disor-
ders caused by increased levels of IFN (McGlasson and Hunt,
2017). However, the results of this study indicate that the thera-
peutic inhibition of IFNAR signaling in the brain might not be
without potential consequences, given the pivotal role of
this pathway in host defense and the importance of basal levels
of IFNAR signaling for synaptic plasticity described here under
physiological conditions.STAR+METHODS
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Anti-GFAP, mouse monoclonal Sigma-Aldrich Cat#G3893; RRID:AB_477010
Anti-IBA1 (Polyclonal rabbit purified antibody) Synaptic Systems Cat# 234 003; RRID:AB_10641962
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Mouse IgG1 kappa Isotype Control (P3.6.2.8.1) Thermo Fisher Scientific Cat# 14-4714-82; RRID:AB_470111
Chemicals, Peptides, and Recombinant Proteins
BenchStable DMEM Thermo Fisher Scientific Cat# A4192101
Bovine Serum Albumin Sigma-Aldrich Cat# A7906
CaCl2 Applichem Lot: 4U010421
CNQX disodium salt Tocris Cat# 1045
cOmplete Protease Inhibitor Cocktail Sigma-Aldrich Cat# 04693116001
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GIBCO CTS Neurobasal Medium Fisher Scientific Cat# 12043479
GIBCO Fetal Bovine Serum Fisher Scientific Cat# 11573397
GIBCO HBSS 10X Fisher Scientific Cat# 14065049
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Merck Millipore Cat# WBLUR0100
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NaHCO3 Roth Art.-Nr. HN01.1
(Continued on next page)
Cell Reports 31, 107666, May 19, 2020 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Permount Mounting Medium Fisher Scientific Cat# SP15-100
PhosSTOP Sigma-Aldrich Cat# 04 906 837 001
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Recombinant Mouse IFN-beta Protein, CF R&D Systems Cat# 8234-MB-010/CF
Strychnine Sigma-Aldrich CAS Nr. 57-24-9
TFB-TBOA Tocris Cat# 2532
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FD Rapid GolgiStain Kit FD NeuroTechnologies, Inc. Cat# PK401
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C57BL/6J OlaHsd mice Harlan-Winkelmann or
Janvier
Cat# 057 (H-W)
GFAP-Cre +/ mice NCI Mouse Repository Cat# 01XN3
IFNAR / mice Kamphuis et al., 2006 N/A
IFNAR fl/fl mice Kamphuis et al., 2006 N/A
IFN-b / mice Erlandsson et al.,1998 N/A
Nes-Cre +/ mice The Jackson Laboratory Cat# 003771
Syn1-Cre +/ mice The Jackson Laboratory Cat# 003966
Recombinant DNA
pAcGFP1-F Vector Clontech Cat# 632511
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Fiji BioVoxxel RRID:SCR_015825 http://www.biovoxxel.de/
IntraCell Version 1.5 (C) 2000 Institute for
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Prism 7 GraphPad https://www.graphpad.com/scientific-
software/prism/
Video Mot 2 TSE Systems https://www.tse-systems.com
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OPEN ACCESSEXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
In this study male and female C57BL/6J OlaHsd mice, also referred to as wild-type (WT), were originally purchased from Harlan-Win-
kelmann, Germany, or Janvier, France and bred under standard housing conditions.
Inactivation of the IFNAR1 gene in embryonic stem cells was achieved by homologous recombination (M€uller et al., 1994). The find-
ings of M€uller and colleagues defined that, mice lacking the IFNAR1 subunit of the IFN receptor (conventional knockout) were
completely unresponsive to all type I IFN, including IFN-a and IFN-b. This suggests that the existence of IFNAR1 polypeptide chain
is likewise essential for IFN to mediate signal transduction. IFNAR1-deficient mice (Ifnar/) did not show any overt anomalies, how-
ever, they were unable to cope with viral infections efficiently despite otherwise normal immune responses (M€uller et al., 1994; Wei
et al., 2017). Ifnar/ animals were extensively backcrossed (more than 10 generation) with C57BL/6J OlaHsd mice to ensure a ho-
mogeneous genetic background. Ifnar/ mice were bred with Wt animals and then hemizygous animals were used to generate
Ifnar/ mice to control the genetic drift in the colony.
In order to enable selective depletion of IFNAR on different CNS cell types, conditional IFNARmice (Ifnarfl/fl) (Kamphuis et al., 2006)
were intercrossed with transgenic mice that express Cre recombinase in neuroectodermal cells including neurons, astrocytes and
oligodendrocytes (Nestin-Cre, Cre transgene starting from embryonic day 12.5, E12.5, NesCre+/IFNARfl/fl) (Tronche et al., 1999),
neurons (Synapsin I-Cre (E12.5), Syn1Cre+/IFNARfl/fl) (Zhu et al., 2001) or astrocytes (E14.5, GFAPCre+/IFNARfl/fl) (Bajenaru
et al., 2002), respectively, and backcrossed into theC57BL/6JOlaHsd background. The astrocyte specificity of GFAPCre+/IFNARfl/fl
mice has already been described previously (Chhatbar et al., 2018). In this line Cre recombinase activity in a subpopulation of adult
neural stem cells in the subventricular zone was distinguished before, however, GFAP-Cre mice are reported to have no Cre recom-
binase activity in postnatal or adult neural stem cells or their progeny from the hippocampus or other brain regions (Gregorian et al.,
2009). Thus, GFAP-Cre mice are particularly useful for selective targeting of astrocytes (Bajenaru et al., 2002; Chhatbar et al., 2018).
Ifnb/ mice (Erlandsson et al., 1998) were backcrossed into the C57BL/6J OlaHsd background in the same way as Ifnar/ mice.
All micewere bred and kept under specific-pathogen-free conditions in the central mouse facility of the Twincore, Centre for Exper-
imental and Clinical Infection Research, Hannover, and at the Helmholtz Centre for Infection Research, Braunschweig. In this study,
both male and female mice were used.
The experiments performed with mice were approved according to the animal welfare law in Germany. All protocols used in this
project have been reviewed and approved by the local committees at TU Braunschweig and the authorities (LAVES, Oldenburg, Ger-
many - 33.19-42502-04-18/2995) according to the national guidelines of the animal welfare law in Germany (‘Tierschutzgesetz in der
Fassung der Bekanntmachung vom 18.Mai 2006 (BGBl. I S. 1206, 1313), das zuletzt durch Artikel 20 des Gesetzes vom 9. Dezember
2010 (BGBl. I S. 1934) geändert worden ist.’).
Primary embryonic hippocampal culture
For different pharmacological approaches, primary embryonic hippocampal cultures were prepared as previously described (Kaech
and Banker, 2006). Briefly, pregnant femaleWT or Ifnar/ mice were rapidly killed by cervical dislocation for harvesting hippocampi
at embryonic day E18.5. Next, the uterus was opened and the embryos were collected and decapitated immediately. The heads of
the embryos were immersed in ice-cold Gey’s balanced salt solution (GBSS, Sigma-Aldrich). Subsequently, brains of embryos were
isolated, hippocampi were dissected and immersed in ice-cold GBSS. Hippocampi were transferred into a tube containing 1 mL of
trypsin-EDTA solution (Sigma-Aldrich) and incubated for 30 min at 37C. After the incubation time, trypsin solution was removed and
hippocampi were washed six times with 1 mL of DMEMmedium (Thermo Fisher Scientific) containing 2% fetal goat serum (Thermo
Fischer Scientific). Afterward, hippocampi were homogenized and dissociated by trituration using a glass pipette and centrifuged for
5 min at 1500 rpm. The supernatant was removed and the cell sediment was resolved in 1 mL of Neurobasal medium (GIBCO) con-
taining glutamine (200 mM), 1% N2 and 2% B-27 (GIBCO) supplements referred as complete medium. 7 3 104 cells in 150 mL of
complete medium were plated on poly-L-lysine (Sigma-Aldrich) coated coverslip (15 mm diameter). The cells were cultured in 24
well plates and incubated for 3 h at 37C. Finally, 350 mL of pre-warmed complete medium was added to each well and plates
were kept in an incubator at 37C for 21 days. Once a week, 100 mL of culture medium per well were replaced by fresh complete
medium.
Acute mouse hippocampal slices
Acute hippocampal slices were prepared from 6-8 weeks old conventional and conditional knockout and respective control mice.
Briefly, mice were deeply anesthetized with 100% CO2 then sacrificed and brains were quickly removed. Right hemispheres were
immersed into ice-cold carbogenated (95%O2 and 5%CO2) artificial cerebrospinal fluid (ACSF) and the left hemispheres were trans-
ferred into the Golgi-Cox staining solution for further morphological analysis. ACSF contained 124 mM NaCl, 4.9 mM KCl, 1.2 mM
KH2PO4, 2.0 mM MgSO4, 2.0 mM CaCl2, 24.6 mM NaHCO3 and 10 mM D-glucose at pH = 7.4. Afterward, the hippocampus was
dissected and transverse hippocampal slices (400 mm) were obtained by using a manual tissue chopper. The hippocampal slices
were transferred to an interface recording chamber (Scientific System Design), where they were incubated at 32C with a constant





For behavioral evaluation, 8-10 weeks old conventional or conditional IFNAR as well as IFN-b knockout mice and respective control
animals were assigned to different groups. All behavioral experiments were performed at the same time of day during the light period
between 9:00 to 16:00 by an experimenter blind to all groups.
Open field test
In this study, spontaneous locomotor activity and explorative behavior of mice were assessed using the open field test as previously
described (Walsh and Cummins, 1976). Briefly, mice were allowed to freely explore the open field apparatus (40cm3 40cm3 40cm)
for 5 min. The central area of the arena was specified as the center part (30cm 3 30cm). Between animals, the apparatus was
completely cleaned with Bacillol to reduce odor cues. Movement data including total distance traveled, average speed and per-
centage of activity in the periphery and center parts of the arena were collected by Video Mot 2 (TSE Systems GmbH, Bad Homburg,
Germany) or ANY-maze (Stoelting, USA) behavioral tracking software.
Morris water maze test
In order to investigate cognitive behavior in mice, spatial learning and memory formation was assessed using the Morris water maze
paradigm. Spatial learning in the Morris water maze is a hippocampus-dependent task where the animals have to locate a hidden
platform using visual cues surrounding the pool (Morris, 1984; Vorhees and Williams, 2006). The maze was comprised of a circular
pool 160 cm in diameter which was filled with water at 19-20 C colored opaque (Titaandioxide, Euro OTC Pharma). The transparent
platform was 10 cm in diameter and hidden 1 cm underneath the surface of the water. Prior to the training, a visible platform task was
performed as a pre-training and used to ensure that swimming ability and visual acuity were intact in all experimental groups, more-
over, this phase was important for the animals to get accustomed to the test situation. During this phase, the animals had two trials
(maximum of 60 s each) per day for three consecutive days to reach the visible platform, the position was alternated during the trials
(Data are not shown). Subsequently, training in the Morris water maze was performed for 8 days with the invisible platform located in
the northwest (NW) quadrant. Each day, animals were placed in the water for four trials, with different starting points (SW, S, E, and
NE) randomly at a 5 min intertrial interval. The animals were permitted to swim freely for 60 s or until the platform was reached. Other-
wise, they were guided to the platform and allowed to sit on it for 20 s.
For qualitative aspects of spatial learning and memory formation during 8 days of acquisition training, the pathway map to find the
platform was analyzed to evaluate different searching strategies. For this purpose, the relative presence in different zones of the
swimming pool including a doughnut-shaped annulus zone (Ring with a diameter of 20 cm at the same distance from the wall as
the platform), the center area (Circular region covering the center until 25 cm distance from the walls, including the platform) and
Wishaw’s corridors (Corridor from the respective starting position leading to the platform with a width of 12 cm) were assessed (Hos-
seini et al., 2018). Over time, mice switch from egocentric hippocampus-independent strategies including scanning characterized by
> 75% presence in the center area, chaining characterized by > 75% presence in the doughnut-shaped annulus zone and random
search characterized by > 80% coverage of the surface to an allocentric direct swimming strategy characterized by > 50% presence
in the Wishaw’s corridors (goal corridor) which depends highly on the hippocampus (Figure S2A) (Garthe et al., 2009; Garthe and
Kempermann, 2013; Whishaw, 2004).
For evaluation of reference memory, three probe trial tests were performed at the third and at the sixth day of the acquisition
training, prior to the training session on that day. Another reference memory test was performed 24 h after the last day of acquisition
training (day 9). During the probe trial, the platform was removed and the animals were allowed to swim freely for 45 s.
All data including swimming time (latency to reach the platform), percentage of time spent in the four quadrants of the pool, per-
centage of time spent in the border (thigmotaxis), annulus (chaining), central circle (scanning) zones and Whishaw’s corridors (direct
swimming) of the pool were collected by Video Mot 2 (TSE Systems GmbH, Bad Homburg, Germany) or ANY-maze (Stoelting, USA)
behavioral tracking software.
Electrophysiological experiments
Field excitatory postsynaptic potentials (fEPSPs) were recorded in the stratum radiatum of the CA1 region in acute hippocampal sli-
ces. Responses were evoked by electrical stimulation of the Schaffer collateral pathway using two monopolar, lacquer coated stain-
less-steel electrodes (5 MU; AM Systems). These stimulation electrodes (S1 and S2) were positioned equidistantly on both sides of
the recording electrode and by this means two independent stimulation pathways could be used for the same CA1 recording region.
For recording fEPSPs (measured as the first slope function), the recording electrode (5 MU; AM Systems) was placed in the CA1 api-
cal dendritic layer (at least 20 mm away from the stratum pyramidale) and signals were amplified by a differential amplifier (Model
1700, AM Systems). The signals were digitized using a CED 1401 analog-to-digital converter (Cambridge Electronic Design). An
input-output curve (afferent stimulation versus fEPSP slope) for assessment of basal synaptic transmission was generated after
the pre-incubation period. Test stimulation intensity was modified to be adjusted to extract fEPSP slope as 40% of the maximal
fEPSP response for both synaptic inputs S1 and S2. To investigate short-term plasticity, a paired-pulse stimulation protocol was
used with two consecutive stimuli with equal intensity from one of the stimulating electrodes in each hippocampal slice. Paired-pulse
facilitation (PPF) was extracted from the fEPSP slopes as a response to the second stimulation over the first one at different interpulse
intervals of 10, 20, 40, 60, 80, and 100ms. To investigate long-term potentiation, 20min after baseline recording LTP was induced bye4 Cell Reports 31, 107666, May 19, 2020
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OPEN ACCESSTheta-burst stimulation (TBS) including four bursts at 100 Hz repeated 10 times in a 200 ms interval. This stimulation was repeated
three times in a 10 s interval. Only healthy sections with a stable baseline were included in the electrophysiological data analysis. The
slope of fEPSPs was measured over time and normalized to the baseline. Data acquisition and offline analysis were performed using
IntraCell software (Version 1.5, LIN, Magdeburg, 2000).
IFNAR1 antibody treatment in electrophysiological recording
To investigate the acute effect of blocking IFN signaling on CA1 hippocampal neurons, blocking antibody treatment during the elec-
trophysiological recording was performed. For this purpose, acute hippocampal slices obtained from 6-8 weeks old Wt mice were
pretreated for 1 h before the recordingwith IFNAR1monoclonal antibody (MAR1-5A3, Functional Grade, eBioscience, Thermo Fisher
Scientific) or mouse IgG1 kappa isotype control antibody (P3.6.2.8.1, Thermo Fisher Scientific) dissolved at the final concentration of
10 mg/ml in ACSF.
Golgi-Cox staining
To investigate the effect of IFN signaling deficiency on hippocampal neuron morphology, Golgi-Cox staining was performed. For this
purpose, the left hemispheres of 6-8 weeks old conventional and conditional knockout and respective control mice were incubated in
FD rapid Golgi stain kit (FD NeuroTechnologies, Inc., Columbia, USA) according to the manufacturer’s protocol. Afterward, hemi-
spheres were blocked in 2% agar and 200 mm thick coronal sections were cut with a vibratome (Leica VT 1000 S) and mounted
on gelatin-coated glass slides. Subsequently, the sections were processed for signal development before being dehydrated through
graded alcohols and mounted using Permount (Fisher Scientific).
Transfection
Three weeks old primary embryonic hippocampal cultures (day in vitro (DIV) 21) were transfected using Plasmid DNA pAcGFP1-F
(farnesylated enhanced green fluorescent protein, CMV promoter, Clontech) to visualize the neurons and allow for further morpho-
logical analysis. For transfection, 1 mg of DNA and 2 mL of Lipofectamine2000 (Invitrogen) per well were mixed separately in 50 mL
pre-warmed Neurobasal medium and incubated at room temperature for 5 min. Afterward, both solutions were combined and incu-
bated for 20 min at room temperature. After the incubation time, the old complete culture medium was collected from each well and
300 mL of fresh pre-warmed Neurobasal medium without any further supplements was added to each well. Subsequently, 100 mL of
transfection solution was added dropwise to each well. Plates were incubated for 50 min at 37C in the incubator. Next, the trans-
fection medium was replaced with old collected complete culture medium and plates were incubated for another 48 hours at 37C in
the incubator before the respective experiment started.
Chemical LTP (cLTP) induction in primary embryonic hippocampal culture
To investigate structural synaptic plasticity, NMDA receptor dependent LTP was induced chemically (cLTP) by glycine. For this pur-
pose, transfected cultures were incubated in 500 mL of Hank’s balanced salt solution (HBSS 1X, GIBCO) for 10 min at room temper-
ature followed by another 10 min incubation in HBSS 1X without magnesium containing 200 mM glycine (AppliChem) and 3 mM
Strychnine (blocker for inhibitory ionotropic glycine receptor) (Sigma-Aldrich) (Fortin et al., 2010). Afterward, the solution was
removed and 500 mL of HBSS 1X per well were added and cells were incubated for another 50 min at room temperature before fix-
ation. Control wells were treated only with HBSS 1X. Finally, cells were fixed using 4% paraformaldehyde (PFA) for 15 min at room
temperature. The cultures were washed three times (each time 5min) with PBS 1X. After washing, the coverslips weremounted using
Fluoro-gel mounting medium (Electron Microscopy Sciences, Hatfield, PA).
Pharmacological treatments
Primary embryonic hippocampal cultures obtained from Wt or Ifnar/ animals were treated with IFN-b (1000 U/ml, R&D Systems)
alone for 10 min or accompanied by glycine and strychnine in HBSS 1X without magnesium for cLTP induction at room temperature.
Then, the cells were incubated in HBSS 1X for another 50 min before fixation. To acutely block IFNAR signaling primary embryonic
hippocampal cultures were treated with mouse IFNAR1 monoclonal antibody (10 mg/ml) (MAR1-5A3, Thermo Fisher Scientific) or
mouse IgG1 kappa isotype control antibody (10 mg/ml) (P3.6.2.8.1, Thermo Fisher Scientific) for 10 min alone or accompanied
with glycine and strychnine in HBSS 1X without magnesium for cLTP induction at room temperature.
To investigate whether IFN-b action depends on ionotropic glutamate receptor signaling primary embryonic hippocampal cultures
were treated with 1000 U/ml IFN-b accompanied by NMDA receptor antagonist, APV (50 mM, (2R)-amino-5-phosphonovaleric acid,
Tocris) and a competitive AMPA receptor antagonist, CNQX (20 mM, 6-cyano-7-nitroquinoxaline-2,3-dione, Tocris) in HBSS 1X
without magnesium for 10 min. Afterward, the cells were incubated for another 50 min in HBSS 1X at room temperature before
fixation.
To investigate the effects of a glial glutamate transporter inhibitor (as an emulator of IFN) on structural synaptic plasticity, primary
embryonic hippocampal cultures were treated with 20 nM TFB-TBOA alone for 10 min or accompanied by glycine and strychnine in
HBSS 1X without magnesium for cLTP induction. Afterward, the cells were incubated for another 50 min in HBSS 1X at room tem-
perature before fixation. TFB-TBOA ((2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate, Tocris) is a potent and se-
lective glial glutamate transporter EAAT1 and EAAT2 inhibitor, nevertheless it has no effect on EAAT4 and EAAT5 or a wide range of
neuronal glutamate receptors and transports (Bozzo and Chatton, 2010). TFB-TBOAwas solved in DMSO and the final concentration




To determine the inflammatory responses andGLAST expression in the hippocampus of mice lacking IFNAR, brains of 6-8 weeks old
conventional and conditional IFNAR knockout and respective control mice were isolated and fixed in 4%paraformaldehyde (PFA) for
24 hours and then cryoprotected in 30% sucrose solution in 0.1 M phosphate buffer (PB) for 24 hours and stored in Tissue-Tek
O.C.T. compound (A.Hartenstein Laborversand) at 70C. For fluorescence immunostaining, 30 mm sections were cut using a
freezing microtome (Frigomobil, R.Jung Heidelberg, Germany). Afterward, five successive sections were washed with PBS 1X
and blocked in PBS 1X solution containing 0.2%Triton X-100, 10%goat serum and 1%BSA for 1 hour at room temperature. Sections
were incubated overnight at 4C with ionized calcium-binding adaptor molecule 1 (IBA-1) (1:1000; rabbit polyclonal, Synaptic Sys-
tem) or EAAT1/GLAST-1/SLC1A3 (Glutamate aspartate transporter) (1:1000; rabbit polyclonal, Novus Biologicals) primary
antibodies diluted in PBS 1X, 0.2% Triton X-100 and 10% goat serum. The secondary antibody was CyTM3-conjugated AffiPure
Goat Anti-Rabbit IgG (H+L) (1:500; Jackson ImmunoResearch, USA) which was diluted in PBS 1X. Sections were washed by PBS
1X thoroughly (30 min) twice and stained with 40,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) subsequently followed by
mounting with Fluoro-gel medium (Electron Microscopy Sciences, Hatfield, PA).
Immunocytochemistry
PFA-fixed cells (on glass coverslips) were washed three times (each 5 min) with PBS 1X and were incubated 1 hour at room temper-
ature with 0.2%Triton X-100 and 1.5%goat serum. The coverslips were washedwith PBS 1X three times (each 5min). After washing,
cells were incubated in a mixture of anti-glial fibrillary acidic protein (GFAP) (1:1000; mouse monoclonal, Sigma–Aldrich) and EAAT1/
GLAST-1/SLC1A3 (1:500; rabbit polyclonal, Novus Biologicals) primary antibodies diluted in 0.2% Triton X-100 and 1.5%goat serum
overnight at 4C. Then, the coverslips were washed thoroughly with PBS 1X for 30 min (3 times) and incubated in CyTM2-conjugated
AffiPure Goat Anti-Rabbit IgG (H+L) (1:500; Jackson ImmunoResearch, USA) and CyTM3-conjugated AffiPure Goat Anti-Mouse IgG
(H+L) (1:500; Jackson ImmunoResearch, USA) secondary antibodies diluted in PBS 1X for 1 hour at room temperature. After washing
three times with PBS 1X (each 10 min), the coverslips were mounted using Fluoro-gel mounting medium (Electron Microscopy Sci-
ences, Hatfield, PA).
Imaging and image analysis
To survey the hippocampal neuron morphology in Golgi-Cox stained slices, second- or third-order branches of apical and basal den-
drites within the CA1 subregion of the hippocampus (10 cells per animal) were imaged in three-dimensions (z stack thickness of 0.5 mm)
using an Axioplan 2 imaging microscope (Zeiss) equipped with a 63X (N.A. 1) oil objective and a digital camera (AxioCamMRm, Zeiss).
In all selected neurons, spine density per micrometer dendrite was calculated using Fiji software (BioVoxxel) on the segments of den-
dritic brancheswith a length ofmore than 60-70 mmwhich were located at least 50 mmaway from the soma. The total number of spines
along the segments of dendritic branches was counted manually by an investigator blinded to all experimental groups.
In primary embryonic hippocampal cultures, only neurons (5 cells per coverslips) without any signs of degeneration or physical
damage were chosen. Images of apical dendrites of neurons were taken and spine density was calculated as described above. In
addition, for further morphological assessment, 20 spines were randomly selected along each dendrite and the spine head diameter
was measured using Fiji software (BioVoxxel) by an investigator blinded to all experimental groups.
Images from the anti-IBA-1 staining in the CA1 region were taken in three-dimensions (z stack thickness of 1 mm) using an Axioplan
2 imaging microscope (Zeiss) microscope equipped with an ApoTomemodule (Zeiss), a 20X objective (N.A. 0.8) and a digital camera
(AxioCam MRm, Zeiss). To quantify the density of microglia, a region of interest (ROI) was drawn in each frame of the hippocampal
CA1 subregion and the total number of IBA-1 positive cells with clearly visible nuclei were counted manually by Fiji software (Bio-
Voxxel) and the sampled volume was calculated. Results are expressed as the number of cells per mm3 tissues and then normalized
to control. For morphometric analysis of IBA-1 positive cells, at least 30microglial cells (6 cells per each ROI) were randomly selected
in CA1 hippocampal subregion of anti-IBA-1 stained images from each animal. The total number of primary microglial cell processes
as a possible indicator of activation was counted using Fiji software (BioVoxxel).
Anti-GLAST staining was acquired as described above with the same fluorescent light exposure time (50 ms) in all tested groups.
Image analysis was performed using Fiji software (BioVoxxel). Briefly, the maximum intensity projection of anti-GLAST stained im-
ages was generated. The whole frame (same size in all groups) was considered as a region of interest and mean gray value in
ROIs were measured. In each frame mean gray value of three regions that had no fluorescence was assessed as background
and subtracted fromROIsmean gray value to calculate the corrected total fluorescence intensity. Datawere normalized to the control
group. For the immunohistochemical experiments, all slides were coded and analysis was performed blindly.
The microscopic images of anti-GFAP and anti-GLAST stained primary embryonic hippocampal cultures were acquired with an
Olympus Fluoview1000 Laser Scanning Microscope equipped with a UPLFLN 40 x oil (N.A. 1.3) objective and the software Olympus
Fluoview Ver. 4.0a at a constant laser exposure percentage with the pixel size of 0.099 mm. Image analysis was conducted using Fiji
software (BioVoxxel). Briefly, the maximum intensity projection of anti-GLAST stained images was generated. Using the polygon se-
lection tool, the area of the cell body of a defined astrocyte (GFAP and GLAST positive cell) was measured, and then the GLAST pos-
itive area was calculated as a limited area with a threshold set 5 to 10% in all images (to subtract the background). Using the analyze
particle tool, total immuno-positive areas for GLAST were measured in the cell body and the final data was expressed as the ratio of




To quantify GLAST/excitatory amino acid transporter (EAAT1) expression as a marker of astrocytic glutamate regulation in the hip-
pocampus of 6-8 weeks old conventional and conditional knockout and respective control mice, Western immunoblotting was used.
Briefly, mice were deeply anesthetized with CO2 and decapitated. Hippocampi were dissected and stored at 70C. Hippocampi
were homogenized in lysis buffer (TRIS-HCl 30mM pH 7,5, NaCl 150 mM, 1%Chaps) containing protease (Complete protease inhib-
itor cocktail tablets, Roche) and phosphatase inhibitor (PhosSTOP phosphatase inhibitor cocktail tablets, Roche). The concentration
of isolated protein was measured using Bradford assay. Afterward, samples were added to 4X sodium dodecyl sulfate (SDS) sample
buffer and heated to 96C for 10 min. Equal quantities of protein samples (2 mg) were separated on 10% standard SDS gels. Then
proteins were transferred to the Polyvinylidene fluoride (PVDF) membrane using a semi-dry blot. Membranes were blocked for 1 h at
room temperature in Tris-buffered-saline-0.05% Tween 20 (TBS-T) and 5% non-fat dried milk and then incubated overnight at 4C
with anti-GLAST/EAAT1 (1:3000; rabbit polyclonal, Novus Biologicals) in TBS-T. After washing steps with TBS-T, membranes were
incubated 1 h at room temperature with a secondary antibody (1:20000; anti-Rabbit IgG-Peroxidase antibody produced in goat,
Sigma-Aldrich) in TBS-T. Anti-GAPDH (1:3000; produced in rabbit, affinity isolated antibody, Sigma-Aldrich) in TBS-T was used
as a loading control for protein normalization in western blotting.
Immunoreactive bands were detected on an X-ray film by chemiluminescence using Luminata CrescendoWestern HRP-Substrate
(Merck Millipore). To quantify the expression of GLAST, densitometric analysis was performed using EasyWin32 software (Herolab
GmbH).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed and plotted by GraphPad Prism 7 (GraphPad Software, Inc. USA) and presented as mean ± SEM. Differences in
dendritic spine density, spine head diameter, immunostaining and western blotting data were subjected to a one-way ANOVA or
Student’s t test whereas two-way ANOVA was used for behavioral and electrophysiological experiments. Fisher’s LSD and Tukey’s
multiple comparisons were used as a post hoc test. The minimum significance value was considered as p < 0.05. The minimum
animal numbers in all experiments was calculated a priori using G*Power 3.1.9.4 software (Heinrich Heine University D€usseldorf,
Germany). All statistical analysis and n of different experimental groups were reported in the respective results or figure legends.Cell Reports 31, 107666, May 19, 2020 e7
